In a study by Gaj et al. (2017), AAV9 vectors containing CRISPR/Cas9 were administered into the facial veins of one-day-old transgenic G93A-SOD1 ALS mice to disrupt mutant SOD1 expression [49]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.